StockData
Merck & Co., Inc. logo

Merck & Co., Inc.

MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 9/30250% above fair value
$149.52+3.19 (+2.18%)

Close on Oct 30, 2026Market cap $368.89BP/E 119.6Yield 2.19%

Merck M-M-R II by Quarter

M-M-R II — Worldwide constant-currency (ex-exchange) growth YoY (%) (%)

QuarterlyAnnual

Merck M-M-R II: 1.0% in Q2 2026, up 17.0 pts from a year earlier.

Latest, Q2 2026
1.0%
Period ended Jun 30, 2026
Change on a year earlier
+17.0 pts
-16.0% in Q2 2025
History
19 quarters
Since Q1 2020
Sources
19
Documents cited below

Where the Q2 2026 figure comes from

“|| M-M-R II | 96 | 95 | 1 | % | 1 | % | 201 | 264 | (24) | % | (25) | %”

Source: Form 10-Q (mrk-20260630.htm, filed 2026-08-07) ↗

Reported in Form 10-Q / 10-K MD&A Pediatric Vaccines Disclosure.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedM-M-R II — Worldwide constant-currency (ex-exchange) growth YoY (%) (%)Year on yearSource
Q2 2026Jun 30, 20261.0%+17.0 ptsForm 10-Q (mrk-20260630.htm, filed 2026-08-07) ↗
Q1 2026Mar 31, 2026-39.0%-102.0 ptsForm 10-Q (mrk-20260331.htm, filed 2026-05-04) ↗
Q3 2025Sep 30, 2025-6.0%-12.0 ptsForm 10-Q (mrk-20250930.htm, filed 2025-11-05) ↗
Q2 2025Jun 30, 2025-16.0%-25.0 ptsForm 10-Q (mrk-20250630.htm, filed 2025-08-05) ↗
Q1 2025Mar 31, 202563.0%+61.0 ptsForm 10-Q (mrk-20250331.htm, filed 2025-05-02) ↗
Q3 2024Sep 30, 20246.0%+10.0 ptsForm 10-Q (mrk-20240930.htm, filed 2024-11-06) ↗
Q2 2024Jun 30, 20249.0%+7.0 ptsForm 10-Q (mrk-20240630.htm, filed 2024-08-05) ↗
Q1 2024Mar 31, 20242.0%–Form 10-Q (mrk-20240331.htm, filed 2024-05-03) ↗
Q3 2023Sep 30, 2023-4.0%-3.0 ptsForm 10-Q (mrk-20230930.htm, filed 2023-11-03) ↗
Q2 2023Jun 30, 20232.0%-17.0 ptsForm 10-Q (mrk-20230630.htm, filed 2023-08-07) ↗
Q3 2022Sep 30, 2022-1.0%-11.0 ptsForm 10-Q (mrk-20220930.htm, filed 2022-11-03) ↗
Q2 2022Jun 30, 202219.0%0.0 ptsForm 10-Q (mrk-20220630.htm, filed 2022-08-05) ↗
Q1 2022Mar 31, 202231.0%+52.0 ptsForm 10-Q (mrk-20220331.htm, filed 2022-05-05) ↗
Q3 2021Sep 30, 202110.0%+16.0 ptsForm 10-Q (mrk-20210930.htm, filed 2021-11-05) ↗
Q2 2021Jun 30, 202119.0%+83.0 ptsForm 10-Q (mrk-20210630.htm, filed 2021-08-09) ↗
Q1 2021Mar 31, 2021-21.0%-3.0 ptsForm 10-Q (mrk-20210331.htm, filed 2021-05-05) ↗

Cite this data

StockData. (2026). Merck M-M-R II (%), quarterly Q1 2020–Q2 2026 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/rev-mmr-ii-exfx-yoy

See every metric in the Merck KPI table. Data updated Oct 26, 2026.